Glaucoma Unit, 1st University Department of Ophthalmology, AHEPA Hospital
Thessaloniki, 546 36, Greece
NCT Number: NCT01281020
A 6-month, parallel, non-interventional trial investigating the level of adherence and the impact of dosing in open-angle glaucoma patients who receive either unfixed therapy with latanoprost once in the evening and timolol twice daily, or latanoprost/timolol fixed combination therapy once in the evening. All patients participating in this observational study will be monitored for their adherence with the use of Medication Event Monitoring System (MEMS). At the end of treatment periods treatment satisfaction will be assessed with selected questions from the Treatment Satisfaction Survey-Intraocular Pressure survey. This study will monitor objectively, for the first time, adherence and intraocular pressure control with fixed versus unfixed therapy. Finally it will help us to elucidate the impact of dosing (once-a-day versus three-times-daily) on the level of adherence in glaucoma.
Looking for future studies?
Notify Me18 year–80 year
All sexes
Observational
Thessaloniki, 546 36, Greece
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: 6 months
Rate of asherence with fixed vs unfixed glaucoma therapy
Time frame: 6 months
Objective and subjective signs of ocular surface health
Time frame: 6 months
To document satisfaction with therapy this study will employ questions selected from a validated treatment satisfaction questionnaire (questions 10-15, Treatment Satisfaction Survey-Intraocular Pressure) as published by Day et al (Eye 2006; 20: 583-590). The survey will assess the level of satisfaction and overall quality-of-life with latanoprost/timolol fixed combination versus unfixed therapy in this study.
Aristotle University Of Thessaloniki
Other
A 3-month, Observational Study Investigating With Electronic Monitoring the Level of Adherence and Treatment Satisfaction With Latanoprost/Timolol Fixed Combination Versus Unfixed Therapy in Open-angle Glaucoma
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT01915940
Eye Diseases, Glaucoma
Artesia, California, United States
View Trial DetailsNCT01410188
Eye Diseases, Glaucoma
Artesia, California, United States
View Trial DetailsNCT03235232
Eye Diseases, Glaucoma
Campinas, São Paulo, Brazil
View Trial DetailsNCT02617459
Eye Diseases, Glaucoma
Guangzhou, Guangdong, China
View Trial Details